January 20, 2018 / 12:22 AM / 2 years ago

7th Circuit upholds dismissal of testosterone replacement MDL cases

A federal appeals court on Friday affirmed the dismissal of more than a thousand lawsuits by men who used Pfizer Inc testosterone replacement drug Depo-T, finding the claims were preempted by U.S. Food and Drug Administration approval of the medication’s label.

In a unanimous decision, a three-judge panel of the 7th Circuit U.S. Court of Appeals ruled that U.S. District Judge Matthew Kennelly, who oversees the multidistrict litigation over Depo-T and similar drugs, correctly dismissed the lawsuits in 2015.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2DqBVz1

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below